Clinical Trial Update: Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating allogeneic stem cell transplantation in high-risk CD33+ acute myeloid leukemia, myelodysplastic syndrome, and juvenile myelomonocytic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Juvenile Myelomonocytic Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Allogeneic stem cell transplantation

Snippet

Sponsor: New York Medical College | Conditions: Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia | Phase 1 | Status: TERMINATED